BioMedWire Stocks Archives - Page 3 of 74

FridayNov 07, 2025 10:00 am

Surface Sugars on Immune Cells Linked to the Progression of Psoriasis

A new study has found that immune cells shed the sugars on their surface prior to entering the inflamed skin in people suffering from psoriasis. These findings could lay the foundation for understanding how this disease progresses and lays the groundwork for new approaches to treating psoriasis. The study, whose findings were published in the Science Signaling journal, was conducted by a team in the UK, namely, Doctor Amy Saunders who works at Lancaster University, Doctor Douglas Dyer who works at the University of Manchester, and Doctor Megan Priestley, who was a PhD student to both Sanders and Dyer. Priestley…

ThursdayNov 06, 2025 10:00 am

Review Shows That Neurocognitive Functioning Declines in Patients with CNS Cancers

A review published recently has underscored how patients afflicted with central nervous system (CNS) cancers show significant declines in neurocognitive function. This decline is driven by the location of the malignant tumors and the effects of the treatments given. The narrative review points out declines in processing speed, attention, executive function and memory. The severity and profile of this decline often varies depending on the anatomic location and the biology of the tumor. When the temporal and frontal lobes are involved, the neurocognitive function declines manifest as impacts on higher order skills which facilitate daily independence of patients and their…

TuesdayNov 04, 2025 10:00 am

Lung Cancer Screening is Still Woefully Low in the US, Report Shows

A recent report published by the American Lung Association shows that only a tiny fraction of Americans that are eligible for lung cancer screening undergo the needed screening. This is despite the fact that lung cancer accounts for 20% of all deaths in America attributed to cancer. Deaths due to lung cancer exceed the combined fatalities due to prostate, breast and colon cancer. These statistics would warrant greater rates of lung cancer screening, but on average, just a paltry 5.8% of individuals in America that should get screened actually undergo screening for this cancer, according to the ALA report. In…

FridayOct 31, 2025 10:00 am

How Rural Health Care is Being Impacted by the Federal Funding Landscape

Approximately 20% of people in the U.S. live in a rural area, and they face unique health challenges, such as higher rates of diabetes, obesity and high blood pressure. The recent changes to health care funding brought by the Big Beautiful Bill signed into law in early July are likely to impact rural areas adversely. Kimberly MacPherson, a health policy lecturer at UC Berkeley, highlights how rural health will be impacted. She says the rates of individuals on Medicaid are generally higher in rural areas, so the cuts to funding are bound to have a disproportionate impact upon these people.…

ThursdayOct 30, 2025 10:00 am

$37.5M Grant Announced to Boost Management of Infectious Diseases in the US

On October 15, NETEC (National Emerging Special Pathogens Training & Education Center) announced a grant of $37.5 million targeting HCIDs (High-Consequence Infectious Diseases). Laboratories that do work related to high-consequence pathology and pathogens were urged to call upon their employers to apply and be included among the 75 health care facilities that will be selected to receive part of this large grant. The purpose of this award is to upgrade or provide the chosen facilities with what they need to become recognized as Level 2 NSPS centers having special pathogen management systems. The hospitals selected will receive a maximum of…

TuesdayOct 28, 2025 10:00 am

What Patients Need to Know About the Remission Rate of Glioblastomas

Patients are overwhelmed when they are diagnosed with glioblastoma, the most deadly primary brain cancer. It resists existing treatments and recurs in all patients, with a relatively short survival time averaging 14-18 months. Understanding the rate of remission for this disease can therefore enable patients and their caregivers to have a clear picture of what to expect, and therefore be guided in making any decisions they need to make. We discuss some of the factors influencing remission in GBM. It is important to note that GBM tumors almost always regrow, so remission in this case should be viewed as the…

FridayOct 24, 2025 10:00 am

New LED Therapy Kills Cancer Cells While Sparing Healthy Tissues

Many existing cancer treatments, such as chemotherapy and radiation, don’t distinguish between cancer cells and healthy body cells, and the healthy cells killed alongside cancer cells result in harsh side effects. Researchers are constantly looking for new treatments that are better able to target cancer cells while leaving healthy cells untouched. A new study seems to have uncovered a therapy that could do just that. The study, conducted through a collaboration between a team at University of Texas, Austin, and another team at the University of Porto, Portugal, leveraged a combination of using nano-sized tin particles together with LED light.…

ThursdayOct 23, 2025 10:00 am

New Study Provides Insights on the Cost of Treating Firearm Injuries in America

A study whose findings were recently published has provided insights into the cost of treating injuries resulting from firearms, with a key finding being that Medicaid was billed for a little more than half of the total amount of money spent on these injuries during the period covered by the study. The study, which was conducted by a joint team from the University of Michigan and Northwestern University in Illinois, focused on the initial treatment that individuals received when they visited a hospital after sustaining firearm injuries. For their study, the researchers obtained data on inpatient and emergency department visits…

TuesdayOct 21, 2025 10:00 am

Researchers Develop Nanoparticles That Could Combat Scarring, Inflammation in ARLD

In the U.S., liver disease claims the lives of at least 52,000 people annually. Globally, statistics suggest that 1.5 billion individuals are affected by liver disease. However, ARLD, or alcohol-related liver disease, hasn’t garnered traction within the scientific community, until now. A study undertaken by a team at Texas A&M University has developed a novel therapy that could transform how ARLD is treated. Doctor Jyothi Menon, the lead researcher of this study, explains that the rising cases of liver diseases increase the risk of potentially life-threatening complications like cancer developing from these liver diseases. She adds that this concern drove…

FridayOct 17, 2025 10:00 am

Virtual Brain Tumors Could Transform How Cancer is Treated

Brain tumors, such as glioblastoma, are very hard to treat and even surgery isn’t sufficient to fully remove the tumor since tiny particles of cancerous cells remain and proliferate within a short time. However, ongoing work at Cedars-Sinai promises to transform brain cancer treatment by creating a digital twin of a patient’s tumor and then predicting how the cancer will grow and how it could respond to different therapies. In this way, treatment teams can better personalize treatments for individual patients. At the heart of this work is Kristin Swanson, PhD, who is engaged in pioneering work that combines mathematics…